Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)

TY - JOUR

T1 - Cohort Profile

T2 - International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)

AU - van Santen, Daniela K.

AU - Stewart, Ashleigh

AU - Doyle, Joseph S.

AU - Stoové, Mark A.

AU - Asselin, Jason

AU - Klein, Marina B.

AU - Young, Jim

AU - Berenguer, Juan

AU - Jarrin, Inmaculada

AU - Lacombe, Karine

AU - Wittkop, Linda

AU - Leleux, Olivier

AU - Salmon, Dominique

AU - Bonnet, Fabrice

AU - Rauch, Andri

AU - Mugglin, Catrina

AU - Matthews, Gail

AU - Prins, Maria

AU - Smit, Colette

AU - Boyd, Anders

AU - van der Valk, Marc

AU - Sacks-Davis, Rachel

AU - Hellard, Margaret E.

AU - on behalf of the InCHEHC study group

N1 - Funding Information: The ATHENA database is maintained by Stichting HIV monitoring and supported by a grant from the Dutch Ministry of Health, Welfare and Sport through the Centre for Infectious Disease Control of the National Institute for Public Health and the Environment [ https://www.hiv-monitoring.nl/en/research-using-our-data/submit-research-proposal/rules-acknowledgement ]. Funding Information: The co-EC Study acknowledge all participants and site teams from The Alfred, Melbourne Sexual Health Centre, Prahran Market Clinic, Northside Clinic, Thorne Harbour Health and Melbourne Health; people support from the Australian National Health and Medical Research Council; and investigator-initiated funding support from Bristol Myers Squibb. Funding Information: This study was funded by the Australian Government National Health and Medical Research Council (grant numbers GNT1132902 and GNT2020121). We gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program received by the Burnet Institute. The authors thank the study participants for their contribution to the research. The authors acknowledge the contribution of the ACCESS team members and ACCESS advisory committee members who are not co-authors of this article. The authors also acknowledge all clinical services participating in ACCESS. The list of ACCESS team members, ACCESS advisory committee members, and participating ACCESS services can be found on the ACCESS website [accessproject. org.au]. ACCESS is a partnership between the Burnet Institute, Kirby Institute and National Reference Laboratory. The ATHENA database is maintained by Stichting HIV monitoring and supported by a grant from the Dutch Ministry of Health, Welfare and Sport through the Centre for Infectious Disease Control of the National Institute for Public Health and the Environment [https://www.hiv-monitoring.nl/ en/research-using-our-data/submit-research-proposal/rules-acknowledgement]. Members of the Swiss HIV Cohort Study: Abela I, Aebi-Popp K, Anagnostopoulos A, Battegay M, Bernasconi E, Braun DL, Bucher HC, Calmy A, Cavassini M, Ciuffi A, Dollenmaier G, Egger M, Elzi L, Fehr J, Fellay J, Furrer H, Fux CA, Gunthard € HF (President of the SHCS), Hachfeld A, Haerry D (deputy of ‘Positive Council’), Hasse B, Hirsch HH, Hoffmann M, Hosli € I, Huber M, Kahlert CR (Chairman of the Mother and Child Substudy), Kaiser L, Keiser O, Klimkait T, Kouyos RD, Kovari H, Kusejko K (Head of Data Centre), Martinetti G, Martinez de Tejada B, Marzolini C, Metzner KJ, Muller € N, Nemeth J, Nicca D, Paioni P, Pantaleo G, Perreau M, Rauch A (Chairman of the Scientific Board), Schmid P, Speck R, Stockle € M (Chairman of the Clinical and Laboratory Committee), Tarr P, Trkola A, Wandeler G, Yerly S. The authors would like to thank all clinicians and clinical research technicians participating in the SAIDCC database of the Infectious Diseases Unit of St Antoine Hospital, AP-HP, Paris, France: Jean-Luc Meynard, Jerôme Pacanowski, Laure Surgers, Marie-Caroline Meyohas, Dorothee Chopin, Benedicte Lefebvre, Diane Bollens, Laure Surgers, Nadia Valin, Thibault Chiarabini, Zineb Ouazene, Pauline Campa, Julie Lamarque, Rym Monard, Christian Tran. AQUITAINE (ANRS CO3 AQUITAINE/AquiVIH-NA) scientific committee: P Bellecave, P Blanco, F Bonnet (Chair), S Bouchet, D Breilh, C Cazanave, S Desjardin, V Gaborieau, A Gimbert, M Hessamfar, L Lacaze-Buzy, D Lacoste, ME Lafon, E Lazaro, O Leleux, F Le Marec, G Le Moal, D Malvy, L Marchand, P Mercie, D Neau, I Pellegrin, A Perrier, V Petrov-Sanchez, MO Vareil, L Wittkop (Methodologist). Participating centres: Hôpital Saint Andre, CHU de Bordeaux, Medecine Interne et Maladies Infectieuses (N Bernard, F Bonnet, D Bronnimann H Chaussade, D Dondia, P Duffau, I Faure, M Hessamfar, P Mercie, P Morlat, E Meriglier, F Paccalin, E Riebero, C Rivoisy, MA Vandenhende); Hôpital Pellegrin, CHU de Bordeaux, Maladies Infectieuses et Tropicales (L Barthod, C Cazanave, FA Dauchy, A Desclaux, M Ducours, H Dutronc, A Duvignaud, J Leitao, M Lescure, D Neau, D Nguyen, D Malvy, T Pistone, M Puges, G Wirth); Hôpital Haut-Levêque, CHU de Bordeaux, Medecine Interne et Maladies Infectieuses (C Courtault, F Camou, C Greib, E Lazaro, JL Pellegrin, E Riviere, JF Viallard); Hôpital d’Agen, Medecine Interne (Y Imbert, M Thierry-Mieg, P Rispal); Hôpital de Libourne, Medecine Interne (O Caubet, H Ferrand, S Tchamgoue); Hôpital de Bayonne, Maladies Infectieuses (S Farbos, MO Vareil, H Wille); Hôpital de Dax, Medecine Interne et Maladies Infectieuses (K Andre, L Caunegre, Y Gerard, F Osorio-Perez); Hôpital Saint-Cyr/Villeneuve-surLot, Maladies Infectieuses (I Chossat); Hôpital de Mont de Marsan, Medecine Interne et Maladies Infectieuses (G Iles, Y Gerard, M Labasse-Depis, F Lacassin); Hôpital d’Arcachon, Medecine Interne (A Barret, C Courtault); Hôpital de Perigueux, Medecine Interne et Maladies Infectieuses (B Castan, J Koffi, N Rouanes, A Saunier, JB Zabbe); Hôpital de Pau, Medecine Interne et Maladies Infectieuses (G Dumondin, V Gaborieau); Hôpital d’Orthez, Medecine Interne (Y Gerard); CHU de Poitiers, Medecine Interne et Maladies Infectieuses (G Beraud, G Le Moal, M Catroux, M Garcia, V Giraud, JP Martellosio, F Roblot); Hôpital de Saintes, Medecine Interne (T Pasdeloup); Hôpital d’Angoulême, Medecine Interne (A Riche, M Grosset, S Males, C Ngo Bell); Hôpital de Jonzac, Maladies Infectieuses (T Pasdeloup); Hôpital de Saint Jean d’Angely, Maladies Infectieuses (T Pasdeloup); other departements: Immunology: P Blanco, I Pellegrin; CRB-BBS: C Carpentier, I Pellegrin; Virology: P Bellecave, ME Lafon, C Tumiotto; Pharmacology: S Bouchet, D Breilh, G Miremeont-Salame; Data Collection: D Arma, G Arnou, MJ Blaizeau, P Camps, M Decoin, S Delveaux, F Diarra, L Gabrea, S Lawson-Ayayi, E Lenaud, D Plainchamps, A Pougetoux, B Uwamaliya, K Zara; IT department: V Conte, M Gapillout; Project Team: O Leleux (Project Leader), F Le Marec (Statistician), A Perrier (Data Manager); website: [https://aquivih-nafr/]. MOSAIC collaborators: JTM van der Meer, R Molenkamp, M Mutschelknauss, HE Nobel, HW Reesink, J Schinkel, M van der Valk, JW Vanhommerig (Academic Medical Center, Amsterdam, The Netherlands); GEL van den Berk, K Brinkman, D Kwa, N van der Meche, A Toonen, D Vos (Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands); M van Broekhuizen, FN Lauw, JW Mulder (MC Slotervaart, Amsterdam, The Netherlands); JE Arends, A van Kessel, I de Kroon (University Medical Center Utrecht, Utrecht, The Netherlands); A Boonstra, ME van der Ende, S Hullegie, BJA Rijnders (Erasmus Medical Center, Rotterdam, The Netherlands); TJW van de Laar (Sanquin Blood Supply Foundation, Amsterdam, The Netherlands); L Gras, C Smit (Stichting HIV Monitoring, Amsterdam, The Netherlands); AM Newsum, M Prins, W van der Veldt (Public Health Service of Amsterdam, Amsterdam, The Netherlands). The CoRIS steering committee members: Santiago Moreno, Inma Jarrın, David Dalmau, Maria Luisa Navarro, Maria Isabel Gonzalez, Federico Garcia, Eva Poveda, Jose Antonio Iribarren, Felix Gutierrez, Rafael Rubio, Francesc Vidal, Juan Berenguer, Juan Gonzalez, M Angeles Munoz-Fernandez. Members of the CEASE study group: Protocol Steering Committee—Gail Matthews (Chair, Kirby Institute, University of New South Wales [UNSW] Sydney, Sydney, Australia), David Baker (East Sydney Doctors, Sydney, Australia), Mark Bloch (Holdsworth House Medical Practice, Sydney, Australia), Joanne Carson (Kirby Institute, UNSW Sydney, Sydney, Australia), Gregory Dore (Kirby Institute, UNSW Sydney, Sydney, Australia), Joseph Doyle (Burnet Institute, Melbourne, Australia), Tim Duck (NSW Health, Sydney, Australia), Robert Finlayson (Taylor Square Private Clinic, Sydney, Australia), Margaret Hellard (Burnet Institute, Melbourne, Australia), Hayden Jose [Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), Sydney, Australia], Sarah Lambert (AIDS Council of NSW, Sydney, Australia), Stuart Loveday (Hepatitis NSW, Sydney, Australia), Pip Marks (Kirby Institute, UNSW Sydney, Sydney, Australia), Marianne Martinello (Kirby Institute, UNSW Sydney, Sydney, Australia), Jeffrey Post (Albion Centre, Sydney, Australia), Leila Stennett (Australian Federation of AIDS Organisations, Sydney, Australia), Vanessa Towell (ASHM, Sydney, Australia), Joseph Sasadeusz (Royal Melbourne Hospital, Melbourne, Australia). Coordinating Centre: Kirby Institute, UNSW Sydney, Sydney, Australia—Gail Matthews (Coordinating Principal Investigator), Joanne Carson (Study Coordinator), Gregory Dore (Coordinating Principal Investigator), Ecaterina Filep (Data Manager), Joanne Carson (Study Coordinator), Pip Marks (Clinical Trials Manager), Marianne Martinello (Senior Research Fellow, Statistician), Kathy Petoumenos (Statistician), Ineke Shaw (Systems Manager), Jasmine Yee (Study Coordinator), Lanni Lin (Study Coordinator). Site Principal Investigators—New South Wales: Eva Jackson (Blue Mountains Sexual Health, Sydney, Australia), Nicholas Doong (Dr Doong’s Surgery, Sydney, Australia), David Baker (East Sydney Doctors, Sydney, Australia), Mark Bloch (Holdsworth House Medical Practice, Sydney, Australia), Phillip Read (Kirketon Road Centre, Sydney, Australia), Archana Sud (Nepean Sexual Health, Sydney, Australia), Gregory Dore (St Vincent’s Hospital, Sydney, Australia), Anna McNulty (Sydney Sexual Health Centre, Sydney, Australia), Robert Finlayson (Taylor Square Private Clinic, Sydney, Australia), Jeffrey Post (Albion Centre, Sydney, Australia), Shailendra Sawleshwarkar (Western Sydney Sexual Health, Sydney, Australia); Queensland: Diane Rowling (Brisbane Sexual Health Clinic, Brisbane, Australia); South Australia: David Shaw (Royal Adelaide Hospital, Adelaide, Australia); Victoria: Richard Moore (Northside Clinic, Melbourne, Australia). Site Coordinators—New South Wales: Vincenzo Fragomeli (Blue Mountains Sexual Health, Sydney, Australia), Shane Hewitt (Dr Doong’s Surgery, Sydney, Australia), Melissa Benson (East Sydney Doctors, Sydney, Australia), Annabelle Caspersz (Holdsworth House Medical Practice, Sydney, Australia), Rosie Gilliver (Kirketon Road Centre, Sydney, Australia), Vincenzo Fragomeli (Nepean Sexual Health, Sydney, Australia), Alison Sevehon, Fiona Peet, Rebecca Hickey (St Vincent’s Hospital, Sydney, Australia), Ruthy McIver (Sydney Sexual Health Centre, Sydney, Australia), Ching Tan (Taylor Square Private Clinic, Sydney, Australia), Raghib Ahmad (Albion Centre, Sydney, Australia), Holly Miller, Tichaona Jaricha (Western Sydney Sexual Health, Sydney, Australia); Queensland: Fiona Taylor (Brisbane Sexual Health Clinic, Brisbane, Australia); South Australia: Catherine Ferguson (Royal Adelaide Hospital, Adelaide, Australia); Victoria: Susan Boyd, Sian Gowalds (Northside Clinic, Melbourne, Australia). The co-EC Study acknowledge all participants and site teams from The Alfred, Melbourne Sexual Health Centre, Prahran Market Clinic, Northside Clinic, Thorne Harbour Health and Melbourne Health; people support from the Australian National Health and Medical Research Council; and investigator-initiated funding support from Bristol Myers Squibb. Scientific Committee of the ANRS CO13 HEPAVIH Study Group: D Salmon (co-Principal Investigator), L Wittkop (co-Principal Investigator and Methodologist), P Sogni (co-Principal Investigator), P Carrieri, L Esterle (Project Manager), P Trimoulet, J Izopet, L Serfaty, MA Valantin, G Pialoux, J Chas, K Barange, A Naqvi, E Rosenthal, A Bicart-See, O Bouchaud, A Gervais, C Lascoux-Combe, C Goujard, K Lacombe, C Duvivier, D Neau, P Morlat, F Bani-Sadr, F Boufassa, C Solas, H Fontaine, L Piroth, A Simon, D Zucman, F Boue, P Miailhes, E Billaud, H Aumaître, D Rey, G Peytavin, O Zaegler, representative members of the sponsor (clinical research and pharmacovigilance department), representative members of patient organization including TRT5). Canadian co-infection Cohort (CTN222) co-Investigators–Drs Lisa Barrett, Jeff Cohen, Brian Conway, Curtis Cooper, Pierre Côte, Joseph Cox, M John Gill, Shariq Haider, Mark Hull, Valerie Martel-Laferriere, Erica E M Moodie, Neora Pick, Danielle Rouleau, Aida Sadr, Steve Sanche, Roger Sandre, Marie-Louise Vachon, Sharon Walmsley, Alexander Wong. Project Coordination: Isabelle Robichaud. Data Management: Shouao Wang. We also acknowledge the Canadian co-infection Cohort participants, the study coordinators and the nurses for their assistance with study coordination, participant recruitment and care. Funding Information: This study was funded by the Australian Government National Health and Medical Research Council (grant numbers GNT1132902 and GNT2020121). We gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program received by the Burnet Institute. Acknowledgements

PY - 2024/2

Y1 - 2024/2

KW - cohort studies

KW - consortium

KW - elimination

KW - Hepatitis C

KW - HIV

UR - https://www.scopus.com/pages/publications/85184835488

U2 - 10.1093/ije/dyad154

DO - 10.1093/ije/dyad154

M3 - Article

C2 - 38066671

AN - SCOPUS:85184835488

SN - 0300-5771

VL - 53

JO - International Journal of Epidemiology

JF - International Journal of Epidemiology

IS - 1

M1 - dyad154

ER -